Contraceptives Drugs and Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-24

Pages: 135 Pages

Report ld: 2334499

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.

The global market for Contraceptives Drugs and Devices was estimated to be worth US$ 28510 million in 2023 and is forecast to a readjusted size of US$ 43020 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030

Contraceptives Drugs and Devices Market Size(US$)

M= millions and B=billions

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Contraceptives Drugs and Devices, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Contraceptives Drugs and Devices by region & country, by Type, and by Application.

The Contraceptives Drugs and Devices market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives Drugs and Devices.

Market Segmentation

Report Metric
Details
Report Title
Contraceptives Drugs and Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 43020 million
CAGR(2024-2030)
6%
Market Size Available for Years
2024-2030
Global Contraceptives Drugs and Devices Companies Covered
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer, Inc
Bayer AG
Mayer Laboratories, Inc
The Female Health Company
Cooper Surgical, Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Veru, Inc
Organon Group of Companies
Agile Therapeutics
TherapeuticsmMD, Inc
Afaxys, Inc
Mithra Pharmaceuticals
Abbvie
Global Contraceptives Drugs and Devices Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Contraceptives Drugs and Devices Market, Segment by Type
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Global Contraceptives Drugs and Devices Market, Segment by Application
Female
Male
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Contraceptives Drugs and Devices manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Contraceptives Drugs and Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Contraceptives Drugs and Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Contraceptives Drugs and Devices Product Introduction
    1.2 Global Contraceptives Drugs and Devices Market Size Forecast
    1.3 Contraceptives Drugs and Devices Market Trends & Drivers
        1.3.1 Contraceptives Drugs and Devices Industry Trends
        1.3.2 Contraceptives Drugs and Devices Market Drivers & Opportunity
        1.3.3 Contraceptives Drugs and Devices Market Challenges
        1.3.4 Contraceptives Drugs and Devices Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Contraceptives Drugs and Devices Players Revenue Ranking (2023)
    2.2 Global Contraceptives Drugs and Devices Revenue by Company (2019-2024)
    2.3 Key Companies Contraceptives Drugs and Devices Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Contraceptives Drugs and Devices Product Offered
    2.5 Key Companies Time to Begin Mass Production of Contraceptives Drugs and Devices
    2.6 Contraceptives Drugs and Devices Market Competitive Analysis
        2.6.1 Contraceptives Drugs and Devices Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Contraceptives Drugs and Devices Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2023)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
        3.1.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
    3.2 Global Contraceptives Drugs and Devices Sales Value by Type
        3.2.1 Global Contraceptives Drugs and Devices Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Contraceptives Drugs and Devices Sales Value, by Type (2019-2030)
        3.2.3 Global Contraceptives Drugs and Devices Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Female
        4.1.2 Male
    4.2 Global Contraceptives Drugs and Devices Sales Value by Application
        4.2.1 Global Contraceptives Drugs and Devices Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Contraceptives Drugs and Devices Sales Value, by Application (2019-2030)
        4.2.3 Global Contraceptives Drugs and Devices Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region
    5.1 Global Contraceptives Drugs and Devices Sales Value by Region
        5.1.1 Global Contraceptives Drugs and Devices Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Contraceptives Drugs and Devices Sales Value by Region (2019-2024)
        5.1.3 Global Contraceptives Drugs and Devices Sales Value by Region (2025-2030)
        5.1.4 Global Contraceptives Drugs and Devices Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Contraceptives Drugs and Devices Sales Value, 2019-2030
        5.2.2 North America Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Contraceptives Drugs and Devices Sales Value, 2019-2030
        5.3.2 Europe Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Contraceptives Drugs and Devices Sales Value, 2019-2030
        5.4.2 Asia Pacific Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Contraceptives Drugs and Devices Sales Value, 2019-2030
        5.5.2 South America Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Contraceptives Drugs and Devices Sales Value, 2019-2030
        5.6.2 Middle East & Africa Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Contraceptives Drugs and Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Contraceptives Drugs and Devices Sales Value
    6.3 United States
        6.3.1 United States Contraceptives Drugs and Devices Sales Value, 2019-2030
        6.3.2 United States Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Contraceptives Drugs and Devices Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Contraceptives Drugs and Devices Sales Value, 2019-2030
        6.4.2 Europe Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Contraceptives Drugs and Devices Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Contraceptives Drugs and Devices Sales Value, 2019-2030
        6.5.2 China Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Contraceptives Drugs and Devices Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Contraceptives Drugs and Devices Sales Value, 2019-2030
        6.6.2 Japan Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Contraceptives Drugs and Devices Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Contraceptives Drugs and Devices Sales Value, 2019-2030
        6.7.2 South Korea Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Contraceptives Drugs and Devices Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Contraceptives Drugs and Devices Sales Value, 2019-2030
        6.8.2 Southeast Asia Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Contraceptives Drugs and Devices Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Contraceptives Drugs and Devices Sales Value, 2019-2030
        6.9.2 India Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Contraceptives Drugs and Devices Sales Value by Application, 2023 VS 2030

7 Company Profiles
    7.1 Teva Pharmaceutical Industries Ltd
        7.1.1 Teva Pharmaceutical Industries Ltd Profile
        7.1.2 Teva Pharmaceutical Industries Ltd Main Business
        7.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Products, Services and Solutions
        7.1.4 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
    7.2 Church & Dwight Co. Inc
        7.2.1 Church & Dwight Co. Inc Profile
        7.2.2 Church & Dwight Co. Inc Main Business
        7.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Products, Services and Solutions
        7.2.4 Church & Dwight Co. Inc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.2.5 Church & Dwight Co. Inc Recent Developments
    7.3 Reckitt Benckiser Plc
        7.3.1 Reckitt Benckiser Plc Profile
        7.3.2 Reckitt Benckiser Plc Main Business
        7.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Products, Services and Solutions
        7.3.4 Reckitt Benckiser Plc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.3.5 Pfizer, Inc Recent Developments
    7.4 Pfizer, Inc
        7.4.1 Pfizer, Inc Profile
        7.4.2 Pfizer, Inc Main Business
        7.4.3 Pfizer, Inc Contraceptives Drugs and Devices Products, Services and Solutions
        7.4.4 Pfizer, Inc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.4.5 Pfizer, Inc Recent Developments
    7.5 Bayer AG
        7.5.1 Bayer AG Profile
        7.5.2 Bayer AG Main Business
        7.5.3 Bayer AG Contraceptives Drugs and Devices Products, Services and Solutions
        7.5.4 Bayer AG Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.5.5 Bayer AG Recent Developments
    7.6 Mayer Laboratories, Inc
        7.6.1 Mayer Laboratories, Inc Profile
        7.6.2 Mayer Laboratories, Inc Main Business
        7.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Products, Services and Solutions
        7.6.4 Mayer Laboratories, Inc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.6.5 Mayer Laboratories, Inc Recent Developments
    7.7 The Female Health Company
        7.7.1 The Female Health Company Profile
        7.7.2 The Female Health Company Main Business
        7.7.3 The Female Health Company Contraceptives Drugs and Devices Products, Services and Solutions
        7.7.4 The Female Health Company Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.7.5 The Female Health Company Recent Developments
    7.8 Cooper Surgical, Inc
        7.8.1 Cooper Surgical, Inc Profile
        7.8.2 Cooper Surgical, Inc Main Business
        7.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Products, Services and Solutions
        7.8.4 Cooper Surgical, Inc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.8.5 Cooper Surgical, Inc Recent Developments
    7.9 Allergan plc
        7.9.1 Allergan plc Profile
        7.9.2 Allergan plc Main Business
        7.9.3 Allergan plc Contraceptives Drugs and Devices Products, Services and Solutions
        7.9.4 Allergan plc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.9.5 Allergan plc Recent Developments
    7.10 Cipla Limited
        7.10.1 Cipla Limited Profile
        7.10.2 Cipla Limited Main Business
        7.10.3 Cipla Limited Contraceptives Drugs and Devices Products, Services and Solutions
        7.10.4 Cipla Limited Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.10.5 Cipla Limited Recent Developments
    7.11 Merck & Co. Inc
        7.11.1 Merck & Co. Inc Profile
        7.11.2 Merck & Co. Inc Main Business
        7.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Products, Services and Solutions
        7.11.4 Merck & Co. Inc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.11.5 Merck & Co. Inc Recent Developments
    7.12 Veru, Inc
        7.12.1 Veru, Inc Profile
        7.12.2 Veru, Inc Main Business
        7.12.3 Veru, Inc Contraceptives Drugs and Devices Products, Services and Solutions
        7.12.4 Veru, Inc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.12.5 Veru, Inc Recent Developments
    7.13 Organon Group of Companies
        7.13.1 Organon Group of Companies Profile
        7.13.2 Organon Group of Companies Main Business
        7.13.3 Organon Group of Companies Contraceptives Drugs and Devices Products, Services and Solutions
        7.13.4 Organon Group of Companies Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.13.5 Organon Group of Companies Recent Developments
    7.14 Agile Therapeutics
        7.14.1 Agile Therapeutics Profile
        7.14.2 Agile Therapeutics Main Business
        7.14.3 Agile Therapeutics Contraceptives Drugs and Devices Products, Services and Solutions
        7.14.4 Agile Therapeutics Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.14.5 Agile Therapeutics Recent Developments
    7.15 TherapeuticsmMD, Inc
        7.15.1 TherapeuticsmMD, Inc Profile
        7.15.2 TherapeuticsmMD, Inc Main Business
        7.15.3 TherapeuticsmMD, Inc Contraceptives Drugs and Devices Products, Services and Solutions
        7.15.4 TherapeuticsmMD, Inc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.15.5 TherapeuticsmMD, Inc Recent Developments
    7.16 Afaxys, Inc
        7.16.1 Afaxys, Inc Profile
        7.16.2 Afaxys, Inc Main Business
        7.16.3 Afaxys, Inc Contraceptives Drugs and Devices Products, Services and Solutions
        7.16.4 Afaxys, Inc Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.16.5 Afaxys, Inc Recent Developments
    7.17 Mithra Pharmaceuticals
        7.17.1 Mithra Pharmaceuticals Profile
        7.17.2 Mithra Pharmaceuticals Main Business
        7.17.3 Mithra Pharmaceuticals Contraceptives Drugs and Devices Products, Services and Solutions
        7.17.4 Mithra Pharmaceuticals Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.17.5 Mithra Pharmaceuticals Recent Developments
    7.18 Abbvie
        7.18.1 Abbvie Profile
        7.18.2 Abbvie Main Business
        7.18.3 Abbvie Contraceptives Drugs and Devices Products, Services and Solutions
        7.18.4 Abbvie Contraceptives Drugs and Devices Revenue (US$ Million) & (2019-2024)
        7.18.5 Abbvie Recent Developments

8 Industry Chain Analysis
    8.1 Contraceptives Drugs and Devices Industrial Chain
    8.2 Contraceptives Drugs and Devices Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Contraceptives Drugs and Devices Sales Model
        8.5.2 Sales Channel
        8.5.3 Contraceptives Drugs and Devices Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Contraceptives Drugs and Devices Market Trends
    Table 2. Contraceptives Drugs and Devices Market Drivers & Opportunity
    Table 3. Contraceptives Drugs and Devices Market Challenges
    Table 4. Contraceptives Drugs and Devices Market Restraints
    Table 5. Global Contraceptives Drugs and Devices Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Contraceptives Drugs and Devices Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Contraceptives Drugs and Devices Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Contraceptives Drugs and Devices Product Type
    Table 9. Key Companies Time to Begin Mass Production of Contraceptives Drugs and Devices
    Table 10. Global Contraceptives Drugs and Devices Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives Drugs and Devices as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Contraceptives Drugs and Devices Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Contraceptives Drugs and Devices Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Contraceptives Drugs and Devices Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Contraceptives Drugs and Devices Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Contraceptives Drugs and Devices Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Contraceptives Drugs and Devices Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Contraceptives Drugs and Devices Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Contraceptives Drugs and Devices Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Contraceptives Drugs and Devices Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Contraceptives Drugs and Devices Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Contraceptives Drugs and Devices Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Contraceptives Drugs and Devices Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Contraceptives Drugs and Devices Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Contraceptives Drugs and Devices Sales Value by Region (2019-2024) & (%)
    Table 27. Global Contraceptives Drugs and Devices Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Contraceptives Drugs and Devices Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Contraceptives Drugs and Devices Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Contraceptives Drugs and Devices Sales Value, (2025-2030) & (US$ Million)
    Table 31. Teva Pharmaceutical Industries Ltd Basic Information List
    Table 32. Teva Pharmaceutical Industries Ltd Description and Business Overview
    Table 33. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Teva Pharmaceutical Industries Ltd (2019-2024)
    Table 35. Teva Pharmaceutical Industries Ltd Recent Developments
    Table 36. Church & Dwight Co. Inc Basic Information List
    Table 37. Church & Dwight Co. Inc Description and Business Overview
    Table 38. Church & Dwight Co. Inc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Church & Dwight Co. Inc (2019-2024)
    Table 40. Church & Dwight Co. Inc Recent Developments
    Table 41. Reckitt Benckiser Plc Basic Information List
    Table 42. Reckitt Benckiser Plc Description and Business Overview
    Table 43. Reckitt Benckiser Plc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Reckitt Benckiser Plc (2019-2024)
    Table 45. Reckitt Benckiser Plc Recent Developments
    Table 46. Pfizer, Inc Basic Information List
    Table 47. Pfizer, Inc Description and Business Overview
    Table 48. Pfizer, Inc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Pfizer, Inc (2019-2024)
    Table 50. Pfizer, Inc Recent Developments
    Table 51. Bayer AG Basic Information List
    Table 52. Bayer AG Description and Business Overview
    Table 53. Bayer AG Contraceptives Drugs and Devices Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Bayer AG (2019-2024)
    Table 55. Bayer AG Recent Developments
    Table 56. Mayer Laboratories, Inc Basic Information List
    Table 57. Mayer Laboratories, Inc Description and Business Overview
    Table 58. Mayer Laboratories, Inc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Mayer Laboratories, Inc (2019-2024)
    Table 60. Mayer Laboratories, Inc Recent Developments
    Table 61. The Female Health Company Basic Information List
    Table 62. The Female Health Company Description and Business Overview
    Table 63. The Female Health Company Contraceptives Drugs and Devices Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of The Female Health Company (2019-2024)
    Table 65. The Female Health Company Recent Developments
    Table 66. Cooper Surgical, Inc Basic Information List
    Table 67. Cooper Surgical, Inc Description and Business Overview
    Table 68. Cooper Surgical, Inc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Cooper Surgical, Inc (2019-2024)
    Table 70. Cooper Surgical, Inc Recent Developments
    Table 71. Allergan plc Basic Information List
    Table 72. Allergan plc Description and Business Overview
    Table 73. Allergan plc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Allergan plc (2019-2024)
    Table 75. Allergan plc Recent Developments
    Table 76. Cipla Limited Basic Information List
    Table 77. Cipla Limited Description and Business Overview
    Table 78. Cipla Limited Contraceptives Drugs and Devices Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Cipla Limited (2019-2024)
    Table 80. Cipla Limited Recent Developments
    Table 81. Merck & Co. Inc Basic Information List
    Table 82. Merck & Co. Inc Description and Business Overview
    Table 83. Merck & Co. Inc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Merck & Co. Inc (2019-2024)
    Table 85. Merck & Co. Inc Recent Developments
    Table 86. Veru, Inc Basic Information List
    Table 87. Veru, Inc Description and Business Overview
    Table 88. Veru, Inc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Veru, Inc (2019-2024)
    Table 90. Veru, Inc Recent Developments
    Table 91. Organon Group of Companies Basic Information List
    Table 92. Organon Group of Companies Description and Business Overview
    Table 93. Organon Group of Companies Contraceptives Drugs and Devices Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Organon Group of Companies (2019-2024)
    Table 95. Organon Group of Companies Recent Developments
    Table 96. Agile Therapeutics Basic Information List
    Table 97. Agile Therapeutics Description and Business Overview
    Table 98. Agile Therapeutics Contraceptives Drugs and Devices Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Agile Therapeutics (2019-2024)
    Table 100. Agile Therapeutics Recent Developments
    Table 101. TherapeuticsmMD, Inc Basic Information List
    Table 102. TherapeuticsmMD, Inc Description and Business Overview
    Table 103. TherapeuticsmMD, Inc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of TherapeuticsmMD, Inc (2019-2024)
    Table 105. TherapeuticsmMD, Inc Recent Developments
    Table 106. Afaxys, Inc Basic Information List
    Table 107. Afaxys, Inc Description and Business Overview
    Table 108. Afaxys, Inc Contraceptives Drugs and Devices Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Afaxys, Inc (2019-2024)
    Table 110. Afaxys, Inc Recent Developments
    Table 111. Mithra Pharmaceuticals Basic Information List
    Table 112. Mithra Pharmaceuticals Description and Business Overview
    Table 113. Mithra Pharmaceuticals Contraceptives Drugs and Devices Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Mithra Pharmaceuticals (2019-2024)
    Table 115. Mithra Pharmaceuticals Recent Developments
    Table 116. Abbvie Basic Information List
    Table 117. Abbvie Description and Business Overview
    Table 118. Abbvie Contraceptives Drugs and Devices Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Contraceptives Drugs and Devices Business of Abbvie (2019-2024)
    Table 120. Abbvie Recent Developments
    Table 121. Key Raw Materials Lists
    Table 122. Raw Materials Key Suppliers Lists
    Table 123. Contraceptives Drugs and Devices Downstream Customers
    Table 124. Contraceptives Drugs and Devices Distributors List
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
    Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Contraceptives Drugs and Devices Product Picture
    Figure 2. Global Contraceptives Drugs and Devices Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Contraceptives Drugs and Devices Sales Value (2019-2030) & (US$ Million)
    Figure 4. Contraceptives Drugs and Devices Report Years Considered
    Figure 5. Global Contraceptives Drugs and Devices Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Contraceptives Drugs and Devices Revenue in 2023
    Figure 7. Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Picture
    Figure 9. Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Picture
    Figure 10. Global Contraceptives Drugs and Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Contraceptives Drugs and Devices Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Female
    Figure 13. Product Picture of Male
    Figure 14. Global Contraceptives Drugs and Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Contraceptives Drugs and Devices Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Contraceptives Drugs and Devices Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Contraceptives Drugs and Devices Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Contraceptives Drugs and Devices Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Contraceptives Drugs and Devices Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Contraceptives Drugs and Devices Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Contraceptives Drugs and Devices Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Contraceptives Drugs and Devices Sales Value (%), (2019-2030)
    Figure 27. United States Contraceptives Drugs and Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Contraceptives Drugs and Devices Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Contraceptives Drugs and Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Contraceptives Drugs and Devices Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Contraceptives Drugs and Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Contraceptives Drugs and Devices Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Contraceptives Drugs and Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Contraceptives Drugs and Devices Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Contraceptives Drugs and Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Contraceptives Drugs and Devices Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Contraceptives Drugs and Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Contraceptives Drugs and Devices Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Contraceptives Drugs and Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Contraceptives Drugs and Devices Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Contraceptives Drugs and Devices Sales Value by Application (%), 2023 VS 2030
    Figure 48. Contraceptives Drugs and Devices Industrial Chain
    Figure 49. Contraceptives Drugs and Devices Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation

Description

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.

The global market for Contraceptives Drugs and Devices was estimated to be worth US$ 28510 million in 2023 and is forecast to a readjusted size of US$ 43020 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Contraceptives Drugs and Devices, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Contraceptives Drugs and Devices by region & country, by Type, and by Application.

The Contraceptives Drugs and Devices market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives Drugs and Devices.

Market Segmentation

Related Reports

Global Contraceptives Drugs and Devices Market Research Report 2023
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There
Published: 2023-09-08
Pages: 97
USD 2900.00
(Single User License)
Global Contraceptives Drugs and Devices Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There
Published: 2023-05-30
Pages: 113
USD 5600.00
(Single User License)
Global Contraceptives Drugs and Devices Market Insights, Forecast to 2029
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There
Published: 2023-09-08
Pages: 117
USD 4900.00
(Single User License)
Global Contraceptives Drugs and Devices Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There
Published: 2023-05-26
Pages: 103
USD 3350.00
(Single User License)
Global Contraceptives Drugs and Devices Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There
Published: 2023-10-18
Pages: 114
USD 3350.00
(Single User License)
Contraceptives Drugs and Devices - Global Market Insights and Sales Trends 2024
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There
Published: 2023-11-13
Pages: 110
USD 3350.00
(Single User License)
Global Contraceptives Drugs and Devices Market Research Report 2024
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There
Published: 2024-01-31
Pages: 99
USD 2900.00
(Single User License)
Global Contraceptives Drugs and Devices Market Insights, Forecast to 2030
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There
Published: 2024-04-26
Pages: 114
USD 4900.00
(Single User License)
Global Contraceptives Drugs and Devices Market Research Report 2025
The global market for Contraceptives Drugs and Devices was valued at US$ 32030 million in the year 2
Published: 2025-02-25
Pages: 93
USD 2900.00
(Single User License)
Contraceptives Drugs and Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Contraceptives Drugs and Devices was estimated to be worth US$ 32030 million i
Published: 2025-02-25
Pages: 128
USD 3950.00
(Single User License)